- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07284771
MUSCLE-ML: Multimodal Integration of Muscle Strength, Structure by Machine Learning for Precision Rehabilitation After ACL Injury
The goal of this clinical trial is to use machine learning (ML) to predict functional recovery by integrating muscle-related factors and other relevant parameters for identification of non-responders to conventional rehabilitation. The main questions it aims to answer are:
Do deficit clusters lead to poorer functional recovery compared to non-deficit clusters? Does an ML-derived composite score that integrates quadriceps/hamstring strength and size outperform isolated metrics in predicting RTP success?
Researchers will compare deficit clusters against non-deficit clusters to determine if deficit clusters lead to poorer functional recovery.
Participants will:
Return for 5 follow-up timepoints in total for PRO and functional assessments including pre-operation, 1-, 3-, 6- and 12-months post-operation.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: muriel XIAO
- Phone Number: (852)35053311
- Email: lingqingxiao@cuhk.edu.hk
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Unilateral ACL injury and plan for ACLR
- Commit the post-operation physiotherapy in Prince of Wales Hospital
Exclusion Criteria:
- Preoperative radiographic signs of arthritis
- Patient non-compliance to the rehabilitation program
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Deficit group
|
no intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
International Knee Documentation Committee score
Time Frame: 6- and 12-months post-operation
|
6- and 12-months post-operation
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Shu Hang YUNG, Chinese University of Hong Kong
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2025.374
- 23241901 (Other Grant/Funding Number: Health and Medical Research Fund)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Machine Learning
-
Tang-Du HospitalCompleted
-
Singapore General HospitalNot yet recruitingMachine LearningSingapore
-
Chang Gung Memorial HospitalCompletedIntubation | Machine LearningTaiwan
-
Hao LiuCompletedMachine Learning | Degenerative Lumbar Diseases | CageChina
-
University of North Carolina, Chapel HillBill and Melinda Gates FoundationCompletedPregnancy Related | Machine Learning | Gestational AgeUnited States, Zambia
-
Shanghai 6th People's HospitalRecruitingMachine Learning | Ultrasound | Blood Volume AnalysisChina
-
Marmara UniversityCompletedVoiding Disorders | Machine Learning | Voiding DysfunctionTurkey
-
University of PennsylvaniaCompletedArtificial Intelligence | Machine Learning | Diagnostic ImagingUnited States
-
Shanghai Zhongshan HospitalNot yet recruitingMachine Learning | Near-infrared Vision | Microcirculatory Status
-
Nanjing First Hospital, Nanjing Medical UniversityCompletedCardiac Surgery | Machine Learning | Phenotyping | Hemodynamic Parameters
Clinical Trials on No Intervention: Observational Cohort
-
Huashan HospitalZhejiang Cancer Hospital; Shanghai Zhongshan Hospital; Tongji Hospital; Qilu Hospital... and other collaboratorsRecruitingHead and Neck Squamous Cell Carcinoma | Patient Derived Organoid | Drug Sensitive Test in VitroChina
-
Institut Cancerologie de l'OuestNot yet recruiting
-
University of CalgaryRecruiting
-
Guangzhou Women and Children's Medical CenterNot yet recruitingNEC - Necrotizing Enterocolitis
-
Centre Leon BerardNutricia, Inc.Not yet recruitingSmell Disorder | Taste Alterations | Eating Behavior ChangesFrance
-
Trakya UniversityRecruitingFrailty and Nottingham Hip Fracture Score for Predicting 90-Day Mortality After Hip Fracture SurgeryFrailty | Hip Fracture | Proximal Femur FractureTurkey (Türkiye)
-
Washington University School of MedicineVanderbilt University Medical Center; University of Abuja Teaching HospitalNot yet recruitingPreeclampsia (PE) | Cardiovascular Biomarkers | Preeclampsia (PE) RiskNigeria
-
Heinrich-Heine University, DuesseldorfRoche Pharma AG; Maria Hilf Clinics GmbH, Mönchengladbach; German Multiple Sclerosis...RecruitingMultiple Sclerosis | Fatigue Syndrome, Chronic | Sleep Disorders | Primary Progressive Multiple Sclerosis | Secondary Progress Multiple Sclerosis | Remitting-Relapsing Multiple SclerosisGermany
-
Instituto de Investigación Sanitaria de la Fundación...Hospital General Universitario Gregorio Marañon; Fundació d'investigació Sanitària... and other collaboratorsRecruiting
-
The First Hospital of Jilin UniversityNot yet recruitingCritical Illness | Adult | ICU